USD 3.20 billion
Immunohematology Market Size, Share, Growth Analysis, By Product(Immunohematology analyzer, Immunohematology reagent), By End Use(Hospitals, Blood banks, Diagnostic laboratories ), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35G2186 |
Region:
Global |
Published Date: October, 2024
Pages:
157
|Tables:
34
|Figures:
74
Immunohematology Market Insights
Immunohematology Market size was valued at USD 1.92 Billion in 2023 and is poised to grow from USD 2.01 Billion in 2024 to USD 2.89 Billion by 2032, growing at a CAGR of 4.63% during the forecast period (2025-2032).
Technological innovations in hematology and the introduction of new products are expected to drive significant growth in the market. Hospitals and research facilities are shifting their preference to automated instrumentation and integration of different functions in a single platform, further increasing growth
Leukemia is a disease associated with blood and lymphatic organs. This includes sickle cell anemia, thalassemia, lymphoma, leukemia and hemophilia. According to the World Health Organization, about 4,74,519 new cases of leukemia were reported in 2020 and more than 3,11,594 deaths due to leukemia in 2020. Increasing incidence of cancer in the world is one of the driving the growth of the industry. Furthermore, activities such as improving healthcare, better government policies and increasing R&D expenditure on diagnosis and treatment of various blood disorders are expected to have a positive impact on the industry.
The growing occurrence of blood-associated problems, inclusive of anemia, blood malignancies, hemorrhagic sicknesses, and blood-borne infections raise the demand for hematological testing. Thus, numerous studies have been carried out to evaluate the efficacy and accuracy of automated immunohematology analyzers.
US Immunohematology Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Blood banks
Fastest Growth
Immunohematology analyzer
Growth Rate
10.5% CAGR
Global Immunohematology Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Immunohematology Market Segmental Analysis
Global Immunohematology Market is segmented by Product, End Use, and region. Based on Product , the market is segmented into Immunohematology analyzer, Immunohematology reagent. Based on End Use, the market is segmented into Hospitals, Blood banks, Diagnostic laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Analysis by Product
As per immunohematology market outlook, the immunohematology reagent segment is dominant in the market. Immunohematology reagents are essential for accurate blood group determination and antibody detection. These reagents, including anti-sera, blood clots, and red cells, ensure accurate and reliable test results. Their demand is consistent, as they are consumables required for every test conducted using immunohematology systems. Also, innovations in reagent formulation, such as longer shelf life and increased sensitivity, contributed to the growth of the market. However, with increasing adoption of automation and technological advancements, the immunohematology analyzers segment is growing the fastest. Hospitals and blood banks are increasingly investing in automated systems to meet the increasing demand for efficient and accurate testing, especially in developed regions.
The immunohematology analyzer segment is the fastest growing in the market. Immunohematology analyzers play an important role in blood processing, immunohistochemistry, and matching methods. These devices improve the accuracy, efficiency and speed of diagnostic workflows, making them indispensable for blood banks, hospitals and diagnostic laboratories. The adoption of advanced analyzers equipped with artificial intelligence (AI) and machine learning algorithms has further improved error detection and real-time data analysis. Their ability to handle high-throughput testing has made them a preferred choice in regions with the high demand for blood transfusion services.
Analysis by End Use
As per immunohematology market analysis, the blood banks segment is currently dominant due to its critical role in maintaining blood supply chains and ensuring transfusion safety. Blood banks normally carry out high-volume testing, making them major consumers of immunohematology products, particularly automated systems and reagents. Blood banks are a vital component of the immunohematology market, as they offer secure and appropriate blood supply. These facilities rely closely on immunohematology device for blood grouping, antibody testing and cross-matching to make sure the safety and compatibility of blood transfusions. Increasing volumes of voluntary blood donations and authorities plans to modernize blood banks. Blood banks also cater to nearby and national emergencies, making them critical participants to market expansion.
The hospitals segment is the fastest growing, driven by the increasing adoption of advanced diagnostic technologies in healthcare facilities. The rising incidence of complex surgeries and chronic conditions also fuels growth in this segment. Hospitals are important end-users in the immunohematology market, as blood quality and compatibility analysis are needed for a wide range of procedures affecting surgery, trauma care, and chronic disease management. Large hospitals with advanced infrastructure are increasingly adopting automated immunohematology analyzers to enhance efficiency and minimize human error in critical testing scenarios. The demand for immunohematology products in hospitals is driven by the rising prevalence of chronic diseases and aging populations.
Global Immunohematology Market By Product (%)
To get detailed analysis on other segments, Request For Free Sample Report
Immunohematology Market Regional Insights
As per immunohematology market outlook, North America is the dominant region with improved healthcare, high prevalence of blood disorders and huge investment in medical technology. The U.S. leads the market due to well-established blood banks, robust research and development activities, and widespread adoption of automated immunohematology systems. Favorable government initiatives, such as blood safety regulations and reimbursement policies, further bolster market growth. Furthermore, the rising company focuses on adopting various key strategies such as agreements, partnerships, and product launches to increase the availability of technologically advanced products in the market. Companies such as Bio-Rad Laboratories and Ortho Clinical Diagnostics have a strong presence in North America, providing state-of-the-art solutions that meet stringent regulatory standards.
Asia-Pacific is the fastest growing region in immunohematology market, with rising healthcare costs, increasing incidence of blood diseases and increasing awareness of blood safety. Increasing demand for advanced diagnostic tools in countries such as China, India and Japan are driven by population growth and increasing burden of chronic diseases. Additionally, government programs promoting voluntary blood donations and the modernization of blood banks are accelerating market growth. The region's lower cost of manufacturing has attracted global players to set up production facilities and distribution networks, further enhancing access to immunohematology products.
Global Immunohematology Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Immunohematology Market Dynamics
Immunohematology Market Drivers
Technological Advances in Immunohematology
-
The technological advancements in immunotherapy devices and the techniques are fueling the growth of the market. Modern automated analyzers have improved accuracy, reduced testing time and increased productivity in laboratories. The integration of artificial intelligence (AI) and machine learning into immunohematology systems has enabled real-time tracking and accurate matching of blood types and antigens, reducing human error.
Increasing Prevalence of Blood Disorders and Chronic Diseases
-
The increasing incidence of blood disorders such as anemia, hypertension, leukemia is a major driver for immunohematology industry. According to the World Health Organization (WHO), the global burden of anemia and blood-borne diseases continues to rise, prompting the healthcare systems to invest in advanced equipment for diagnosis such as immunohematology analyzers.
Immunohematology Market Restraints
Limited Expertise and Resources in Developing Areas
-
Inadequate healthcare facilities and insufficient funding modernized blood banks exacerbates troubles leading to the underutilization of advanced immunohematology technology. In regions with low voluntary blood donation costs, the availability of blood samples for the testing remains limited, in addition limiting the adoption of immunohematology merchandise and solutions. Despite the growing demand for blood transfusion services, lack of importance of blood quality and research in many developing countries hinders market expansion.
High Cost of Immunohematology Equipment and Testing
-
The increasing cost of immunohematology analyzers and diagnostic kits is a major barrier to immunohematology market growth especially in low- and middle-income countries. Advanced system requires huge investments, making them unavailable in small fitness facilities and blood banks. Additionally, ongoing maintenance costs and the need for professional employees to operate those structures are growing. As a result, many institutions in resource-constrained settings are unable to adopt state-of-the-art immunohematology solutions, limiting the market's reach.
Request Free Customization of this report to help us to meet your business objectives.
Immunohematology Market Competitive Landscape
The immunohematology market is highly competitive, driven by the presence of major global players and new startups. Leading companies including Bio-Rad Laboratories, Ortho Clinical Diagnostics, Grifols S.A. and Immucor together dominate the landscape with complete portfolios of automated analyzers, reagents and testing solutions. These big players in R&D will introduce advanced technologies such as molecular immune hematology and AI-driven systems. Strategic partnerships and collaborations are common, as companies work with healthcare providers, blood banks and research institutes to expand their markets. For example, Ortho Clinical Diagnostics recently partnered with several hospitals to deploy its high-throughput immunohematology analyzers, enhancing diagnostic efficiency.
Immunohematology Market Top Player’s Company Profiles
- Grifols
- QuidelOrtho
- Immucor
- Bio-Rad Laboratories
- Beckman Coulter
- Novartis
- Quotient Limited
- Diagast
- Becton, Dickinson and Company
- Thermo Fisher Scientific
- Abbott Laboratories
- BioMérieux
- Hologic, Inc.
- Werfen S.A.
- Merck KGaA
- DiaSorin S.p.A.
- F. Hoffmann-La Roche AG
- Immucor Gamma Biologics
- Tulip Diagnostics Pvt. Ltd.
- Versiti
Immunohematology Market Recent Developments
- May 2022: Nihon Cohden Corporation of India set up a new hematology analyzer reagent plant.
- April 2022: Sysmex Europe launched its new three-stage differential system, the XQ-320 XQ-Series Automated Hematology Analyzer, which offers a range of functions related to quality control and patient data protection.
- January 2021, HealthTab Inc., a subsidiary of Evercore Health Inc. a wholly owned subsidiary, and Abbott, a global healthcare company, entered into a non-exclusive supply chain review agreement for the i-STAT Alinity handheld hematology test in Canada.
Immunohematology Key Market Trends
- Increased Focus on Generic Medications and Rare Blood Group Testing: The growing emphasis on personalized medicinal drug is using the advances in immunotherapy, targeted on detecting rare blood group antigens and adjusting blood transfusion protocols. This immunohematology market trend aligns with the broader push toward precision medication, in which treatment strategies are custom designed primarily based on an affected person's genetic and phenotypic profile. Expanding research efforts on genotyping and molecular diagnostics to reveal complex blood group patterns.
- Increasing Adoption of Automated and Monitoring Systems: The market is witnessing a rapid shift towards automated and point-of-care (POC) systems. This technology also enables rapid and accurate blood type identification and compatibility testing in emergency and remote settings. Systematic processing reduces manual labor, reduces errors, and improves efficiency, which is especially important in high-demand environments such as trauma care facilities.
Immunohematology Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to SkyQuest analysis, the immunohematology industry is poised for sturdy growth, pushed by increasing demand for accurate blood identification and compatibility testing in transfusion therapy. Some of the key drivers are increasing blood diseases and technological advances, while high costs and limited resources act as constraints in developing regions. In a competitive landscape, established leaders such as Bio-Rad and Grifols, emerging players and start-ups that use advanced technologies and a collaborative approach to maintain dominance. Emerging players and startups are carving niches in the specialized areas, contributing to a dynamic and rapidly evolving market. As the global focus on precision medicine and healthcare efficiency intensifies, the market is expected to play an important role in blood transfusion outcomes and improving overall patient care.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 1.83 billion |
| Market size value in 2031 | USD 2.76 billion |
| Growth Rate | 4.63% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Immunohematology Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Immunohematology Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Immunohematology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Immunohematology Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Immunohematology Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Immunohematology Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
